Vertical: CNMBase Year: 2025
Market Size (2025)
$177.62M
Projected (2032)
$340.40M
CAGR (2022–2032)
9.8%
Key Players
11+
Market Overview
The global chitosan agricultural market was valued at USD 177.62 Million in 2025 and is projected to reach USD 340.40 Million by 2032, registering a CAGR of 9.72% during 2026–2032. The market grew from USD 133.87 Million in 2022 to USD 161.68 Million in 2024, and is expected to add USD 162.78 Million in absolute value between 2025 and 2032. Growth is supported by the shift of crop protection and crop nutrition programmes toward biological and low-residue inputs, the formal recognition of chitosan as a low-risk plant protection substance in the European Union and the United States, and the wider use of seed treatments and post-harvest coatings in high-value horticulture.
Key Findings
By Application: Biostimulant & Plant Defense is the largest segment with a 45.00% share in 2025 (USD 79.93 Million) and is also the fastest-growing segment, with a CAGR of 10.97% over 2026–2032.
By Crop Type: Fruits & Vegetables lead with a 55.00% share in 2025 (USD 97.69 Million), while Cereals & Grains is the fastest-growing segment at a CAGR of 10.71%.
By Region: Asia Pacific is the leading region with a 48.00% share in 2025 (USD 85.26 Million). Middle East & Africa is the fastest-growing region at a CAGR of 11.06%, followed by Latin America at 10.71%.
By Country: China is the leading country market, valued at USD 34.10 Million in 2025 (19.20% of the global market). India is the fastest-growing country, with a CAGR of 12.49% over 2026–2032.
Segmentation Summary
The market is analysed by application (Biostimulant & Plant Defense, Seed Coating, and Post-Harvest & Others), by crop type (Fruits & Vegetables, Cereals & Grains, and Others) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Foliar and soil-applied products that elicit plant defence responses and improve stress tolerance generate the largest share of revenue, while seed coating benefits from the expanding use of biological seed treatments in row crops. Fruits & Vegetables remain the core crop category because growers of high-value horticultural crops are most exposed to residue limits and post-harvest losses.
Competitive Landscape Summary
The market is fragmented. Revenue is spread across specialised chitosan producers, biological crop-input developers and fertiliser groups that carry chitosan-based products within wider biostimulant portfolios. KitoZyme and Tidal Vision (through its Tidal Grow AgriScience division) are the most visible specialists, supported by regulatory approvals, proprietary production and partnership networks. Fytofend, DPH Biologicals and Fertiberia act as challengers through registered elicitors, licensed seed treatments and broad distribution, while Omnia Holdings, Botry-Zen, Novochizol, OMEX, Panvo Organics and Vietnam Food occupy regional or application-specific niches. Licensing, distribution agreements and capacity investment are the main competitive levers.
Challenges and Opportunities
The main challenges are the dependence of most supply on crustacean shell by-products, variability in product specification and field efficacy, and fragmented registration requirements across countries. Opportunities lie in fungal (non-animal) chitosan with consistent specifications, in emerging agricultural economies that are formalising biostimulant and bio-input regulation, and in formulations that allow growers to reduce copper and synthetic fungicide use without loss of crop protection.
Future Outlook
Between 2025 and 2032 the market is expected to almost double, rising by USD 162.78 Million. Biostimulant & Plant Defense is projected to contribute USD 85.85 Million of this increase and Asia Pacific USD 82.32 Million. Post-Harvest & Others is expected to grow more slowly, at a CAGR of 6.44%, as it competes with established wax and edible-coating technologies. Suppliers that combine reliable feedstock, defined product specifications, regulatory dossiers and agronomic evidence are best placed to capture the forecast growth.
The Chitosan Agricultural Market market is projected to grow at a CAGR of 9.8% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Chitosan is a linear polysaccharide composed of β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine units. It is produced by the alkaline deacetylation of chitin, the structural polymer found in the exoskeletons of crustaceans such as shrimp, crab and lobster, and in the cell walls of fungi. Commercial chitosan is characterised by its degree of deacetylation, molecular weight and viscosity, which determine its solubility in dilute acids and its biological activity. For agricultural use it is supplied as powder, as acid-soluble solutions and salts (such as chitosan hydrochloride), as low-molecular-weight chito-oligosaccharides and as formulated products.
In agriculture, chitosan acts as an elicitor that triggers plant defence responses, as a biostimulant that improves growth and tolerance of abiotic stress, as a film-forming agent for seed and fruit coatings, and as a substance with direct antimicrobial activity against a range of fungal and bacterial pathogens.
Included: chitosan, chitosan salts, chito-oligosaccharides and chitosan-based formulations sold for agricultural use, covering foliar and soil-applied biostimulant and plant defence products, seed coating and seed treatment products, post-harvest coatings for fruits and vegetables, and other agricultural uses such as soil amendment and nutrient-solution additives.
Excluded: chitosan used in water treatment, pharmaceuticals and medical devices, food and beverage processing, dietary supplements, cosmetics, textiles and animal feed; and unprocessed chitin or crustacean shell meal that has not been converted into chitosan.
Scope of the Study
Segmentation by Application: Biostimulant & Plant Defense; Seed Coating; Post-Harvest & Others.
Segmentation by Crop Type: Fruits & Vegetables; Cereals & Grains; Others.
Regions and countries: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: historic years 2022–2024, base year 2025, forecast period 2026–2032; CAGR reported for 2026–2032.
Unit: market value in USD Million.
Research Objectives
To define and size the global chitosan agricultural market in value terms for 2022–2032.
To analyse the market by application and crop type and identify the segments with the highest growth potential.
To assess regional and country-level demand across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges that shape the adoption of chitosan in crop production.
To examine the regulatory status of chitosan as a plant protection substance and biostimulant in key markets.
To evaluate the value chain, from shell and fungal feedstock to formulation, distribution and end users.
To profile the competitive environment, including positioning, capabilities and key developments of leading suppliers since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured research process combining secondary research, primary research and analytical modelling. The process began with definition of the market scope and segmentation, followed by collection of data on chitosan production, agricultural input consumption, crop-wise usage patterns and regulatory status. Market values were estimated with top-down and bottom-up approaches, triangulated, and validated through discussions with industry participants. The validated base-year estimates were then projected over the forecast period using a factor-based forecasting model.
Secondary Research
Secondary research was used to build an understanding of the industry, its value chain, the competitive environment and the regulatory framework. The main source types were:
Industry associations: biostimulant and biocontrol industry bodies, fertiliser associations, and seafood processing and chitin industry groups.
Government and regulatory bodies: pesticide and fertiliser regulators, agriculture ministries, food-safety agencies and organic certification authorities, including their registration databases and published regulations.
Company sources: annual reports, investor presentations, product labels, technical data sheets and press releases of chitosan producers and crop-input companies.
Trade and scientific journals: agronomy, plant pathology, post-harvest and polymer science journals, together with agricultural trade publications.
Paid and statistical databases: trade statistics, fisheries and aquaculture production data, crop production statistics and company information databases.
Primary Research
Primary research was conducted to validate secondary findings, fill information gaps and obtain qualitative insight into market dynamics. Interviews were held with participants on both the supply and demand sides of the market.
Supply side: chitosan and chito-oligosaccharide manufacturers, crop-input formulators, distributors of biological products and regulatory consultants.
Demand side: growers of fruits, vegetables and field crops, seed companies, packhouses and post-harvest service providers, and agronomists and crop advisers.
Objectives: to validate market size and segment splits, understand pricing and purchasing behaviour, assess adoption barriers and gather views on future demand and competitive activity.
Market Size Estimation
Top-down approach: the overall chitosan market was established first, and the share attributable to agricultural applications was derived from end-use analysis. The agricultural value was then allocated to applications, crop types, regions and countries using adoption rates, crop area, and the penetration of biological inputs in each market.
Bottom-up approach: country-level demand was built from estimates of treated crop area, application rates and average selling prices for each application, and from the revenues of leading suppliers. Country estimates were aggregated to regional and global totals.
Data triangulation: the results of the two approaches were compared and reconciled. Differences were resolved by weighting the more reliable data points and by validation with primary research, so that segment, regional and country values add up to a consistent global total.
Forecasting Methodology
The forecast was developed by projecting base-year values with a combination of historical trend analysis and factor-based adjustment. Factors considered include crop production and acreage trends, the growth of biological and biostimulant input markets, regulatory developments affecting synthetic pesticides and low-risk substances, organic farming area, feedstock availability and pricing, technology developments in fungal chitosan and oligosaccharide formulations, and macroeconomic conditions affecting farm incomes. Each factor was assessed for its direction and strength of impact over the short, medium and long term, and the resulting growth rates were reviewed for consistency across segments and regions.
Base Year, Forecast Period and Currency
Historic years: 2022, 2023 and 2024.
Base year: 2025.
Forecast period: 2026–2032.
Currency: market values are presented in USD Million.
Assumptions and Limitations
Market values are expressed in nominal USD; exchange-rate movements are assumed to remain within historical ranges over the forecast period.
No major disruption to crustacean by-product supply or to fungal fermentation capacity is assumed.
Current regulatory approvals of chitosan as a low-risk plant protection substance and biostimulant are assumed to remain in force.
Company revenues from chitosan agricultural products are often not reported separately, so supplier-level inputs rely partly on estimation and validation through primary research.
Unregistered and informally traded products in some developing markets are difficult to measure and may be under-represented.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global chitosan agricultural market is fragmented. No single supplier holds a dominant position, and competition takes place between three broad groups: specialist chitosan developers with proprietary production and regulatory dossiers; biological crop-input companies that license or distribute chitosan technologies; and fertiliser and agri-input groups that include chitosan-based products within wider biostimulant portfolios. A large number of technical-grade chitosan manufacturers, particularly in China, India and Southeast Asia, supply formulators and local markets.
Competition is based mainly on product specification and consistency, regulatory approvals and label claims, agronomic evidence, and access to distribution. Price is an important factor in commodity-grade supply but less so for registered, specification-controlled products. Recent competitive activity has centred on licensing and distribution agreements, new registrations, and investment in production capacity, including large-scale upcycling of crustacean shell by-products and fungal fermentation.
Key Player Positioning
Based on product portfolio, regional presence, partnerships and industry experience, the leading companies in the market can be grouped as follows.
Leaders
KitoZyme SA (Belgium): a pioneer of non-animal chitosan produced from Aspergillus niger. Its KitoGreen fungal chitosan is approved in the European Union and the United States for foliar, seed-treatment and post-harvest use and is accepted for EU organic farming. The company out-licenses its technology through partners such as DPH Biologicals and Janssen PMP.
Tidal Vision (Tidal Grow AgriScience), United States: a vertically integrated producer of chitosan from crustacean shell by-products. Its Tidal Grow AgriScience division markets chitosan-based biopesticides, seed treatments and biostimulants, including Spectra, GENBOOST and Chroma. The company raised USD 140 million in Series B funding in February 2025 to build additional production plants.
Challengers
Fytofend SA (Belgium): developer of the COS-OGA elicitor marketed as FytoSave, approved in the European Union as a low-risk active substance and distributed through biocontrol partners.
DPH Biologicals (United States): commercialises ChitoNox FC, a fungal chitosan seed treatment licensed from KitoZyme and sold to United States growers from the 2025 season.
Fertiberia Group (Spain): a major Iberian fertiliser group whose bioscience range includes NeoForce Defender, a chitosan hydrochloride-based elicitor, supported by an extensive distribution network.
Niche Players
Omnia Holdings (South Africa): markets CHITOSTAR, a chitosan and chito-oligosaccharide biostimulant, within its OmniBio range.
Botry-Zen (2010) Ltd (New Zealand): supplies ARMOUR-Zen and related chitosan-based biofungicides for grapes and horticulture.
Novochizol SA (Switzerland): develops chitosan nanoparticle delivery systems for biostimulant and biopesticide applications.
OMEX Agriculture (United Kingdom): offers a chitosan elicitor within its specialty crop-nutrition portfolio.
Panvo Organics (India): manufactures agricultural-grade chitosan for formulators.
Vietnam Food JSC (Vietnam): upcycles shrimp by-products into chitin, chitosan and agricultural inputs.
Competitor Dashboard
The dashboard below rates each profiled company on four parameters relevant to the chitosan agricultural market.
Threat of New Entrants: Medium
Basic-substance status in the EU and minimum-risk status in the US lower regulatory barriers compared with conventional pesticides.
Securing reliable feedstock, consistent product specifications and agronomic evidence requires time and investment.
Established distribution relationships and brand trust with growers favour existing suppliers.
Bargaining Power of Suppliers: Medium
Shell feedstock is concentrated in seafood-processing regions and is subject to seasonal and price variation.
A large number of chitosan manufacturers, particularly in Asia, gives formulators a choice of technical-grade suppliers.
Fungal fermentation offers an alternative supply route, reducing reliance on any single feedstock.
Bargaining Power of Buyers: Medium
Large growers, packhouses and distributors can compare chitosan with many other biological and conventional products.
Buyers are price-sensitive where product benefits are not clearly demonstrated.
Products with registrations, organic approval or proven trial results are harder to substitute, which limits buyer leverage.
Threat of Substitutes: High
Other biostimulants such as seaweed extracts, humic substances, protein hydrolysates and microbial products compete for the same budget.
Conventional and copper-based fungicides offer more consistent disease control under high pressure.
Waxes and other edible coatings are established in post-harvest applications.
Intensity of Competitive Rivalry: Medium
The market is fragmented, with specialists, biological companies and fertiliser groups competing.
Competition is based on product quality, regulatory approvals, agronomic support and partnerships rather than price alone.
Strong market growth reduces direct pressure on established suppliers.
Threat of New Entrants: Medium; Low-risk regulatory status offset by feedstock, specification and distribution requirements.
Bargaining Power of Suppliers: Medium; Concentrated shell feedstock, but many manufacturers and fungal alternatives.
Bargaining Power of Buyers: Medium; Wide product choice, limited by registrations and proven performance.
Threat of Substitutes: High; Other biostimulants, conventional fungicides and established coatings.
Intensity of Competitive Rivalry: Medium; Fragmented market with differentiation on quality, approvals and partnerships.
Market estimates by geography (2032)
InsightAsia Pacific leads with $167.58M by 2032, while Middle East & Africa is projected to grow fastest at a 11.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $27.14M | $42.45M | $65.87M | 9.3% | 19% |
| Europe | $30.23M | $46.31M | $70.46M | 8.8% | 21% |
| Asia Pacific | $63.52M | $103.58M | $167.58M | 10.2% | 49% |
| Latin America | $9.13M | $15.25M | $25.36M | 10.8% | 7% |
| Middle East & Africa | $3.86M | $6.60M | $11.13M | 11.2% | 3% |
| Total | $133.87M | $214.19M | $340.40M | 9.8% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$340.40M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Biostimulant & Plant Defense | $165.78M | 11.0% | 49% |
| Seed Coating | $105.56M | 10.3% | 31% |
| Post-Harvest & Others | $69.07M | 6.7% | 20% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Chitosan Agricultural Market covering market dynamics, competitive landscape, and strategic outlook.
The Chitosan Agricultural Market market is projected to reach $340.40M by 2032, growing at 9.8% CAGR. The Biostimulant & Plant Defense segment holds the largest share.
The chitosan agricultural market sits at the intersection of three larger markets: biological crop protection, plant biostimulants and post-harvest technology. Its growth is shaped by regulation of synthetic pesticides and residues, by the economics of high-value crop production, and by the supply of chitin-rich feedstock from the seafood and fermentation industries. The global market is projected to grow at a CAGR of 9.72% over 2026–2032.
This chapter assesses the macro and micro factors influencing the market and describes its main drivers, restraints, opportunities, trends and challenges. The impact scores presented in the growth factor analysis are analyst assessments based on secondary research and industry discussions. Each score is given on a scale of 1 to 10, where 10 represents the strongest impact, for three periods: 2026–2027, 2028–2030 and 2031–2032.
Regulatory Recognition of Chitosan as a Low-Risk Crop Protection Substance
Chitosan holds an unusually favourable regulatory position compared with most crop protection actives. In the European Union, chitosan hydrochloride was approved as a basic substance under Regulation (EC) No 1107/2009 through Commission Implementing Regulation (EU) No 563/2014, and chitosan itself was approved as a basic substance by Commission Implementing Regulation (EU) 2022/456, which took effect in April 2022. Basic substances do not require the full authorisation process applied to conventional plant protection products, which lowers the cost of bringing chitosan products to growers. In the United States, chitosan has long been exempt from the requirement of a tolerance on raw agricultural commodities under 40 CFR 180.1072, and in November 2022 the Environmental Protection Agency published a final rule adding chitosan and its salts to the list of active ingredients permitted in minimum-risk pesticide products, effective January 2023. These approvals allow growers and food retailers to use chitosan without residue concerns, at a time when the number of available synthetic fungicides is being reduced through non-renewals and stricter maximum residue limits. As regulators continue to restrict older chemistries, chitosan products are increasingly positioned as residue-free tools within integrated disease management programmes.
Rapid Adoption of Biostimulants and Biological Inputs
The biostimulant category has gained formal regulatory recognition in several major agricultural markets, giving products such as chitosan a clearer route to market. The EU Fertilising Products Regulation (EU) 2019/1009 created a dedicated plant biostimulant product function category, applicable since July 2022, which allows CE-marked biostimulants to be sold across the single market. India brought biostimulants under the Fertiliser (Control) Order through a 2021 amendment and revised the registration procedure in 2024. Brazil enacted its Bio-inputs Law (Law No. 15,070 of December 2024), and in the United States, the Plant Biostimulant Act of 2025 was introduced in both chambers of Congress to establish a federal definition. Large crop-input companies and distributors have expanded their biological portfolios in response to grower demand and retailer residue requirements. Within this environment, the Biostimulant & Plant Defense segment is projected to grow from USD 79.93 Million in 2025 to USD 165.78 Million by 2032, at a CAGR of 10.97% over 2026–2032, the highest rate among applications.
Demand for Residue-Free Produce and Reduction of Post-Harvest Losses
Fruits and vegetables accounted for 55.00% of the market in 2025. Growers of these crops face strict maximum residue limits and retailer specifications that are often tighter than legal limits, and they treat crops close to harvest, when residue-free inputs are most valuable. Food loss is a further driver: the Food and Agriculture Organization of the United Nations has estimated that around 14 percent of food produced globally is lost between harvest and retail. Chitosan coatings form a semi-permeable film on fruit surfaces that slows respiration and moisture loss and inhibits decay organisms, while pre-harvest chitosan sprays reduce latent infections that develop during storage. Packhouses and exporters of berries, grapes, citrus, stone fruit and tropical fruit are testing and adopting such coatings to extend shelf life and reduce reliance on synthetic post-harvest fungicides. The growth of organic production, in which chitosan is permitted under the EU organic production rules, adds further demand from fruit and vegetable growers.
Growth of Biological Seed Treatments
Seed treatment is one of the fastest-growing routes for biological products because it delivers an active ingredient precisely at sowing, at low dose and low cost per hectare. Chitosan seed coatings form a protective film around the seed, can stimulate germination and early vigour, and prime defence responses against soil-borne pathogens and nematodes. Recent commercial launches illustrate the momentum: DPH Biologicals introduced a fungal chitosan seed treatment for United States growers under licence from KitoZyme for the 2025 season, and Tidal Grow AgriScience launched its chitosan seed treatment in Canada in 2025. Seed companies are also seeking biological components to add value to treated seed packages. The Seed Coating segment is projected to grow from USD 53.29 Million in 2025 to USD 105.56 Million by 2032, at a CAGR of 10.24% over 2026–2032, while Cereals & Grains, which are largely treated through seed applications, form the fastest-growing crop segment at a CAGR of 10.71%.
Fungal and Non-Animal Chitosan
Chitosan produced from fungal biomass, such as Aspergillus niger, offers a consistent, traceable and allergen-free alternative to shell-derived material. It avoids animal by-product requirements and seasonal supply risk, and suits growers and food chains that prefer non-animal inputs. Fungal chitosan has already obtained regulatory approvals in the European Union and the United States and has been accepted for EU organic production. Expansion of fermentation capacity and lower production costs would allow suppliers to offer specification-controlled products at scale, addressing one of the main restraints on the market.
Expansion in Emerging Agricultural Economies
Emerging economies offer the highest growth rates. India is projected to grow at a CAGR of 12.49%, Brazil at 10.94% and Saudi Arabia at 12.34% over 2026–2032. These countries are formalising biostimulant and bio-input regulation, expanding horticulture and export-oriented fruit production, and in several cases have local shrimp processing industries that can supply feedstock. Suppliers that establish local production, distribution partnerships and registrations early can build strong positions in these markets.
Co-Formulation and Reduction of Copper and Synthetic Fungicides
Copper compounds remain important in organic and conventional disease control, but they are under regulatory pressure. In the European Union, copper compounds were renewed as candidates for substitution under Regulation (EU) 2018/1981, with use limited to 28 kg per hectare over seven years. Chitosan can be combined with reduced doses of copper, sulphur or synthetic fungicides to maintain efficacy while lowering active-ingredient loads, and encapsulation systems based on chitosan nanoparticles can improve the delivery of other actives. These approaches allow chitosan suppliers to enter mainstream spray programmes as partners rather than as stand-alone alternatives.
Dependence on Crustacean Feedstock and Supply Volatility
Most chitosan is still produced from shrimp and crab shell waste generated by seafood processing, concentrated in China, Southeast Asia, India and a small number of other coastal producing regions. Supply is affected by seasonal catches, aquaculture disease outbreaks, competing uses of shell waste and the cost of the demineralisation and deproteinisation steps, which consume acids, alkalis and water. Animal-derived chitosan must also comply with animal by-product rules in markets such as the European Union, and may raise allergen and labelling questions for some food chains. These factors can lead to price fluctuations and supply interruptions, which make it difficult for formulators to offer stable pricing to growers.
Variability in Product Quality and Field Performance
The biological activity of chitosan depends on its source, degree of deacetylation, molecular weight and formulation. Products sold under the same generic name can therefore perform very differently, and field results vary with crop, disease pressure, timing and weather. Chitosan generally acts by inducing plant defences rather than by direct, curative control, so it rarely matches the consistency of conventional fungicides under high disease pressure. Inconsistent results reduce grower confidence and make agronomists cautious about recommending chitosan as a stand-alone treatment, which limits adoption to complementary roles in spray programmes.
Fragmented and Uneven Regulatory Treatment
While chitosan enjoys low-risk status in the European Union and the United States, the regulatory route differs widely across markets and between uses. A product making plant protection claims may need pesticide registration, while the same substance positioned as a biostimulant or fertiliser falls under different rules, data requirements and labelling restrictions. In United States organic production, chitosan has not been added to the National List as an active substance; a 2021 vote of the National Organic Standards Board on a petition to allow it for plant disease control did not pass. Such differences increase compliance costs for suppliers that wish to sell in several countries and slow the launch of new products.
Challenge: Demonstrating Return on Investment to Growers
Growers adopt new inputs when they see a reliable yield, quality or cost benefit. For elicitors and biostimulants, benefits are often preventive and vary between seasons, which makes them harder to demonstrate than the effect of a conventional fungicide or fertiliser. Suppliers need multi-season trial data, local agronomic support and clear use recommendations to convert trial users into regular customers.
Trend: Shift Toward Defined, Specification-Controlled Products
Suppliers are moving from generic chitosan powders toward defined products, including chito-oligosaccharides, chitosan salts with specified molecular weight, and complexes such as COS-OGA, which combines chito-oligosaccharides with oligogalacturonides and is approved in the European Union as a low-risk active substance. Defined products give more predictable results and support stronger regulatory dossiers and label claims.
Trend: Circular Economy and Vertical Integration
Upcycling seafood processing waste into chitosan is attracting investment as part of circular-economy strategies. Tidal Vision raised USD 140 million in Series B funding in February 2025 to build new production plants, and producers such as Vietnam Food process tens of thousands of tonnes of shrimp by-products a year into chitin, chitosan and agricultural inputs. Vertical integration from feedstock to finished formulation gives producers greater control over quality and cost.
Trend: Partnership- and Licensing-Led Commercialisation
Specialist chitosan developers increasingly reach growers through partners. Examples include KitoZyme licensing its fungal chitosan to DPH Biologicals for seed treatment and granting Janssen PMP evaluation rights for post-harvest use, and Biobest distributing the COS-OGA product FytoSave. Such arrangements combine the technical depth of specialists with the market access of larger distributors.
The chitosan agricultural value chain extends from chitin-rich raw materials to growers, seed companies and packhouses. The main stages are described below.
Raw materials and inputs: shrimp, crab and lobster shell by-products from seafood processing are the main feedstock. Fungal biomass from fermentation (notably Aspergillus niger) is a growing alternative, and insect-derived chitin is an emerging source. Process inputs include acids, alkalis, enzymes and water.
Chitin extraction and chitosan manufacturing: shells are demineralised and deproteinised to obtain chitin, which is deacetylated to chitosan. Further processing yields chitosan salts, low-molecular-weight chitosan and chito-oligosaccharides through chemical or enzymatic hydrolysis. Quality is controlled through degree of deacetylation, molecular weight, ash and heavy-metal content.
Formulation: formulators convert technical-grade chitosan into soluble concentrates, wettable powders, seed coating formulations and post-harvest coating emulsions, sometimes combined with nutrients, plant extracts or other biological actives, and obtain the required registrations.
Distribution and channels: products reach the market through agrochemical and fertiliser distributors, biological-product specialists, cooperatives and agricultural retailers, licensing agreements with seed companies, direct sales to large growers and packhouses, and online channels.
End users: growers of fruits, vegetables, cereals, grains and other crops; seed companies applying seed treatments; and packhouses and exporters applying post-harvest coatings.
European Union
Regulation (EC) No 1107/2009 on plant protection products provides for the approval of basic substances.
Commission Implementing Regulation (EU) No 563/2014 approved chitosan hydrochloride as a basic substance from July 2014.
Commission Implementing Regulation (EU) 2022/456 approved chitosan as a basic substance from April 2022, with food-grade specification requirements.
Regulation (EU) 2019/1009 (Fertilising Products Regulation) established the plant biostimulant product function category, applicable since July 2022.
Regulation (EU) 2018/848 on organic production, implemented through Implementing Regulation (EU) 2021/1165, lists chitosan hydrochloride and chitosan among substances authorised for use in organic plant protection.
Regulation (EC) No 1069/2009 on animal by-products applies to chitosan derived from crustacean shells.
United States
The Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) governs pesticide registration; the EPA lists chitosan among biopesticide active ingredients.
40 CFR 180.1072 exempts poly-D-glucosamine (chitosan) from the requirement of a tolerance in or on raw agricultural commodities.
An EPA final rule published in November 2022 added chitosan and chitosan salts to the list of active ingredients permitted in FIFRA section 25(b) minimum-risk pesticide products, effective January 2023.
Under the USDA National Organic Program, chitosan is not listed as an active substance for plant disease control.
The Plant Biostimulant Act of 2025 was introduced in the Senate and House to create a federal definition of plant biostimulants.
Canada
Amended Fertilizers Regulations under the Fertilizers Act, administered by the Canadian Food Inspection Agency, came into force in October 2020, with a transition period to October 2023; biostimulant-type products are regulated as supplements.
Products with pest control claims require registration with Health Canada's Pest Management Regulatory Agency under the Pest Control Products Act.
Asia Pacific
India: biostimulants were brought under the Fertiliser (Control) Order, 1985 by notification S.O. 882(E) of February 2021 (Schedule VI), and the procedure was revised by S.O. 1963(E) in May 2024. Products with pesticidal claims require registration under the Insecticides Act, 1968.
China: pesticide registration is governed by the Regulations on Pesticide Administration (State Council Decree No. 677, 2017) and administered by the Institute for the Control of Agrochemicals under the Ministry of Agriculture and Rural Affairs; chitosan and amino-oligosaccharins are registered as biochemical pesticide active ingredients.
Latin America
Brazil: Law No. 15,070 of December 2024 (the Bio-inputs Law) establishes a framework for the production, registration and use of bio-inputs, including growth stimulators, building on the National Bio-inputs Programme established by Decree No. 10,375 of 2020.
Mar 2022: KitoZyme; Regulatory Approval; Received US Environmental Protection Agency approval for KitoGreen fungal chitosan, including seed treatment and post-harvest uses.
Apr 2022: KitoZyme; Regulatory Approval; Chitosan, based on KitoZyme's application, approved as a basic substance for plant protection in the European Union.
May 2022: Fytofend / Biobest; Product Launch; FytoSave (COS-OGA) launched in Finland, its first approval in Scandinavia.
Nov 2022: Novochizol / Alpha Chitin; Joint Venture; Joint venture formed to scale up industrial production of Novochizol chitosan nanoparticles, with agriculture as the main focus.
Nov 2022: Tidal Vision; Regulatory; US EPA final rule, following a petition filed by Tidal Vision, added chitosan and chitosan salts to the minimum-risk pesticide active ingredient list, effective January 2023.
May 2023: KitoZyme / Janssen PMP; Partnership; Exclusive worldwide agreement granting Janssen PMP rights to evaluate KitoZyme chitosan for post-harvest protection of fresh produce.
May 2023: Tidal Grow AgriScience; Product Launch; Tidal Vision's agricultural division launched its product platform, including the chitosan biopesticide Spectra.
Dec 2023: KitoZyme; Regulatory Approval; KitoGreen approved for use in EU organic farming under Regulation (EU) 2023/2229.
Jun 2024: DPH Biologicals / KitoZyme; Licensing / Product Launch; Licensing agreement for ChitoNox FC, a fungal chitosan seed treatment for US growers, available from the 2025 season.
Feb 2025: Tidal Vision; Investment / Expansion; Raised USD 140 million in Series B funding to build new chitosan production plants in Europe, Texas and Ohio.
Feb 2025: Tidal Grow AgriScience; Geographic Expansion; Entered Canada with the GENBOOST chitosan seed treatment and Chroma chitosan biostimulant.
Aug 2025: Novochizol / Aquagri; Partnership; Launched the AgrINovo Indo-Swiss project for local production of Novochizol-based agricultural products in India, with IFFCO support.
Aug 2025: Tidal Grow AgriScience; Regulatory Approval; Spectra chitosan biopesticide approved for use in California.
Political
Government programmes to promote bio-inputs and reduce chemical pesticide use, such as Brazil's bio-inputs framework and India's biostimulant regulation, support adoption.
Public funding for circular-economy projects and food-loss reduction benefits chitosan producers that upcycle seafood waste.
Economic
Chitosan products carry a price premium over many commodity inputs, so adoption is sensitive to farm incomes and crop prices.
Feedstock and energy costs affect production economics, while export-oriented horticulture creates willingness to pay for residue-free inputs.
Social
Consumer preference for residue-free, organic and sustainably produced food influences retailer specifications and grower practices.
Grower familiarity with biological products is increasing, but awareness of chitosan remains uneven, particularly among smallholders.
Technological
Advances in enzymatic hydrolysis, fungal fermentation and nano-encapsulation are improving product consistency and performance.
Better understanding of plant immune responses supports the development of targeted elicitor products and application timing.
Environmental
Chitosan is biodegradable and derived from renewable by-products, supporting sustainability claims.
Climate-related abiotic stress and changing disease patterns increase the need for products that strengthen plant resilience.
Processing of shells requires acids, alkalis and water, so producers face pressure to reduce the environmental footprint of extraction.
Legal
Registration routes differ by market and by claim (plant protection, biostimulant or fertiliser), creating compliance costs.
Animal by-product rules, organic certification standards and maximum residue limit regimes shape the products that can be sold and the claims they can carry.
Profiles of 109 companies operating in the Chitosan Agricultural Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Omnia is a 73-year-old South African industrial chemicals group that has repositioned itself as a two-engine primary-sector supplier: crop nutrition (Agriculture) and mining explosives and metallurgical chemicals (Mining, under the BME brand). Both engines are underpinned by the Sasolburg nitric-acid and ammonium-nitrate complex, one of the largest in the SADC region. The group has been rebuilt since its 2019 recapitalisation from a debt-stressed conglomerate into a net-cash, high-payout business. In FY26 it reported R24.2 billion revenue, a 9.0% operating margin and R1.68 billion net cash excluding leases. Its differentiators are its integrated ammonia-derivative supply chain, the Nutriology® agronomy model, AXXIS™ electronic initiation, and a growing international mining footprint in Indonesia, Canada and Australia. The legacy Chemicals segment has been largely exited. On 14 September 2026 the board agreed to recommend a R21.8 billion cash takeover by India's Solar Industries. Omnia is therefore now best analysed as a pending-take-private situation backed by strong standalone fundamentals. --- ### Company's own description In its FY26 results, Omnia describes itself as a diversified chemicals group supplying chemicals, specialised services and solutions to the agriculture, mining and chemicals application industries [FY26-LF]. It says it combines technical innovation with intellectual capital to add value across the supply and service chain. It also says its solutions promote the responsible use of chemicals and are shifting towards cleaner technologies. The group's stated purpose is "innovating to enhance life, together creating a greener future" [IAR26]. The company groups its activities into three reporting industries: Agriculture, Mining and Chemicals. These are supported by a shared Manufacturing and Supply Chain capability centred on Sasolburg [FY26-LF]. ### Independent characterisation Economically, Omnia is a vertically integrated nitrogen-chemistry platform with two value-added downstream channels. **Upstream.** Omnia buys ammonia, historically mainly from a key domestic supplier that underwent extended shutdowns in FY26, and phosphate rock. At Sasolburg it converts these into: - nitric acid - ammonium nitrate (AN) solution - porous granular and prilled AN - ANCN dual salt and calcium nitrate - nitrophosphate-derived intermediates - granulated NPK fertilizers **Downstream channel 1: Agriculture.** Product is sold through a technical-advisory model (Nutriology®) to commercial and small-scale farmers, cooperatives and governments in South Africa and the Rest of Africa. Internationally, the group sells higher-margin biostimulants (humates, fulvates, kelp, microbials) from Australia, Brazil and the USA. **Downstream channel 2: Mining (BME).** AN feeds bulk emulsion explosives, which are delivered by mobile manufacturing units and bundled with AXXIS™ electronic detonators, blast-design software and on-bench services. BME Metallurgy supplies flotation, solvent-extraction and ammonia-derivative reagents to mineral processors. **Residual: Chemicals.** After the FY25–FY26 restructuring, this is a Bulk Trade business that monetises the group's ammonia-derivative and bulk-liquid logistics, plus a Water Care business that is held for sale. **The economic logic.** The integrated asset base lets Omnia allocate scarce AN between agriculture (seasonal) and mining (year-round). It secures supply when competitors face force majeure, and it earns margin on third-party ammonia-derivative sales. These points recur in every results commentary from FY23 to FY26. ### Revenue model Omnia is overwhelmingly a product business. It has no disclosed subscription or licensing revenue. Software and AXXIS™ technology are bundled into blasting contracts, and part of Mining RSA revenue is cost recovery for services and technology [FY26-LF]. Sources: [FY23-LF] for FY22–FY23; [FY25-LF] for FY24–FY25; [FY26-LF] for FY26. In FY26, services were most significant in Mining: R601 million of R9,816 million Mining revenue, or 6.1%. This reflects BME's blasting-services content [FY26-LF]. ### Value-chain position, customers and end markets Source: [FY26-LF]; [IAR26].
Company Headquarters: Tamil Nadu, India Founded: 2006 Workforce: ~200 Company Working: Panvo Organics Pvt Ltd manufactures and sells APIs, nutraceutical ingredients, specialty chemicals and drug intermediates. Company offers products including glucosamine, chitosan, and others. The manufacturing facility of the company is GMP-compliant with an area of 100,000 sq. feet and it owns four separate production lines for various categories of products. The company also owns quality control laboratories including instrumentation, wet-lab and microbiology lab.
3 interactive charts drawn from the Chitosan Agricultural Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Chitosan Agricultural Market By Crop Type
Global Chitosan Agricultural Market By Application
Global Chitosan Agricultural Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
